Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization[J]. Nat Rev Cancer. 2009;9(4):274–84.

Article  CAS  PubMed  Google Scholar 

Roodman GD. Mechanisms of bone metastasis[J]. N Engl J Med. 2004;350(16):1655–64.

Article  CAS  PubMed  Google Scholar 

Gupta GP, Massagué J. Cancer metastasis: building a framework[J]. Cell. 2006;127(4):679–95.

Article  CAS  PubMed  Google Scholar 

Chiang AC, Massagué J. Molecular basis of metastasis[J]. N Engl J Med. 2008;359(26):2814–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arellano DL, Juárez P, Verdugo-Meza A, et al. Bone Microenvironment-Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice[J]. J Bone Miner Res: Off J Am Soc Bone Mine Res. 2022;37(8):1446–63.

Article  CAS  Google Scholar 

Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities[J]. Nat Rev Cancer. 2002;2(8):584–93.

Article  CAS  PubMed  Google Scholar 

Coleman R E, Brown J, Holen I (2020) Bone Metastases[M/OL]//Abeloff’s Clinical Oncology. Elsevier, 809–830.e3[2023–12–06]. https://doi.org/10.1016/B978-0-323-47674-4.00056-6

Tan S, Li D, Zhu X (2020) Cancer immunotherapy: Pros, cons and beyond[J]. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 124: 109821. https://doi.org/10.1016/j.biopha.2020.109821

Landi L, D’Incà F, Gelibter A, et al. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer[J]. J Immunother Cancer. 2019;7(1):316.

Article  PubMed  PubMed Central  Google Scholar 

Galluzzi L, Vacchelli E, Bravo-San Pedro J-M, et al. Classification of current anticancer immunotherapies[J]. Oncotarget. 2014;5(24):12472–508.

Article  PubMed  PubMed Central  Google Scholar 

Kähkönen TE, Halleen JM, MacRitchie G, et al. Insights into immuno-oncology drug development landscape with focus on bone metastasis[J]. Front Immunol. 2023;14:1121878.

Article  PubMed  PubMed Central  Google Scholar 

Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape[J]. Nat Rev Clin Oncol. 2017;14(3):155–67.

Article  CAS  PubMed  Google Scholar 

Fidler IJ. The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited[J]. Nat Rev Cancer. 2003;3(6):453–8.

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell. 2011;144(5):646–74.

Article  CAS  PubMed  Google Scholar 

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell. 2010;140(6):883–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tannehill-Gregg SH, Levine AL, Nadella MVP, et al. The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice[J]. Clin Exp Metas. 2006;23(1):19–31.

Article  CAS  Google Scholar 

Brubaker KD, Brown LG, Vessella RL, et al. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment[J]. BMC Cancer. 2006;6:15.

Article  PubMed  PubMed Central  Google Scholar 

Miller RE, Roudier M, Jones J, et al. RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis[J]. Mol Cancer Ther. 2008;7(7):2160–9.

Article  CAS  PubMed  Google Scholar 

Esposito M, Guise T, Kang Y. The Biology of Bone Metastasis[J]. Cold Spring Harb Perspect Med. 2018;8(6):a031252.

Article  PubMed  PubMed Central  Google Scholar 

Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions[J]. Skeletal Radiol. 1985;14(1):10–9.

Article  CAS  PubMed  Google Scholar 

Dhillon S. Narlumosbart: First Approval[J]. Drugs. 2024;84(1):105–9.

Article  CAS  PubMed  Google Scholar 

Wakabayashi H, Hamaguchi T, Nagao N, et al. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line[J]. Breast Cancer (Tokyo, Japan). 2018;25(5):566–74.

Article  PubMed  Google Scholar 

Senthilkumar R, Lee H-W. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation[J]. Immunobiology. 2009;214(2):153–61.

Article  CAS  PubMed  Google Scholar 

Li B, Wang P, Jiao J, et al. Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis[J]. Front Immunol. 2022;13:824117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boabaid F, Berry JE, Koh AJ, et al. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts[J]. J Periodontol. 2004;75(9):1247–54.

Article  CAS  PubMed  Google Scholar 

Wada T, Nakashima T, Hiroshi N, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease[J]. Trends Mol Med. 2006;12(1):17–25.

Article  CAS  PubMed  Google Scholar 

Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology[J]. Ann N Y Acad Sci. 2008;1143:123–50.

Article  CAS  PubMed  Google Scholar 

Najafi M, Farhood B, Mortezaee K. Contribution of regulatory T cells to cancer: A review[J]. J Cell Physiol. 2019;234(6):7983–93.

Article  CAS  PubMed  Google Scholar 

Janssen LME, Ramsay EE, Logsdon CD, et al. The immune system in cancer metastasis: friend or foe?[J]. J Immunother Cancer. 2017;5(1):79.

Article  PubMed  PubMed Central  Google Scholar 

Feuerer M, Rocha M, Bai L, et al. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients[J]. Int J Cancer. 2001;92(1):96–105.

Article  CAS  PubMed  Google Scholar 

Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation[J]. J Clin Investig. 2007;117(1):122–32.

Article  CAS  PubMed  Google Scholar 

Sawant A, Hensel J A, Chanda D, et al. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells[J]. J Immunol. (Baltimore, Md.: 1950). 2012;189(9):4258–65.

Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours[J]. Nat Rev Immunol. 2012;12(4):253–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantovani A, Locati M. Orchestration of macrophage polarization[J]. Blood. 2009;114(15):3135–6.

Article  CAS  PubMed  Google Scholar